Inbio
UnclaimedBiological Product (except Diagnostic) ManufacturingCharlottesville, VA
Founded
1997
Primary NAICS
325414
CAGE code
3KKR1
Federal awards
$49.1K
Overview
InBio conducts groundbreaking allergen research focused on advancing and improving technologies and testing capabilities related to asthma and allergy.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Biological Product (except Diagnostic) Manufacturing325414
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2025 | Department of Health and Human Services | $0 | 1 |
| 2024 | Department of Health and Human Services | -$7,720 | 4 |
| 2023 | Department of Health and Human Services | $16,100 | 1 |
| 2022 | Department of Health and Human Services | $40,750 | 1 |